Cagent Vascular announced the appointment of Brian Walsh as the new Chief Executive Officer. Brian Walsh, who previously served as Head of Carl Zeiss Meditech Cataract Technology and President and CEO of IanTECH Medical, Inc., brings over 25 years of medical device and health care industry experience in Marketing, Sales, and Executive Leadership to drive the market adoption of Cagent Vascular’ s flagship product, Serranator.
Who to call at Cagent Vascular, and when
A new leader at Cagent Vascular brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Cagent Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Cagent Vascular
Location
150 STRAFFORD AVENUE
Wayne, Pennsylvania, United States
About
Cagent Vascular has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cagent Vascular changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WayneHealthcareHealth Care